Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 7 - Number 1
Costimulation, Coinhibition and Cancer
, 7(1): 15 - 30Brant A. Inman, Xavier Frigola, Haidong Dong and Eugene D. Kwon
DOI: 10.2174/156800907780006878
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
, 7(1): 31 - 40Alexander J. Muller and George C. Prendergast
DOI: 10.2174/156800907780006896
Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance
, 7(1): 41 - 53Pedro Horna and Eduardo M. Sotomayor
DOI: 10.2174/156800907780006940
T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity
, 7(1): 55 - 70Jeurgen Foell and Becker Hewes
DOI: 10.2174/156800907780006841
Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer
, 7(1): 71 - 77Yulia Nefedova and Dmitry I. Gabrilovich
DOI: 10.2174/156800907780006887
Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
, 7(1): 79 - 89Shreya Kanodia, Laura M. Fahey and W. Martin Kast
DOI: 10.2174/156800907780006869
Small Molecule Inhibitors of Stat3 Signaling Pathway
, 7(1): 91 - 107Jinxia Deng, Fedora Grande and Nouri Neamati
DOI: 10.2174/156800907780006922
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net